future glp-1 drugs Didn't take much for the time magazine to do a flip! From “The big promise” to “A metabolic whiplash” A new study came out yesterday that showed that stopping for GLP-1s like Ozempic are among

How KLOW Compares to Individual Peptides KLOW vs Single Peptides When the Blend Makes Sense A common research question: why use the KLOW blend instead of running each peptide individually

, -

Through involvement in mitochondrial transport and biochemical cofactor activity, several ingredients in Lipo-C contribute to investigations of cellular energy conversion and metabolic efficiency

N Engl J Med 377(18):17331745 Hung C-C, Tsai J-C, Kuo H-T, Chang J-M, Hwang S-J, Chen H-C (2013) Dyslipoproteinemia and impairment of renal function in diabetic kidney disease: an analysis of animal studies, observational studies, and clinical trials